Zobrazeno 1 - 10
of 169
pro vyhledávání: '"Yoshinao Soma"'
Autor:
Tamihiro Kawakami, Reiko Shimosaka, Takafumi Kadono, Keiko Onoda, Maho Terashita, Hiroyuki Ohashi, Maya Matsuoka, Hitoshi Kotake, Yoshinao Soma
Publikováno v:
Skin Cancer. 33:201-205
Autor:
Takafumi Kadono, Saki Akino, Yoshinao Soma, Hiroyuki Ohashi, Tamihiro Kawakami, Tatsuro Okano, Sora Takeuchi
Publikováno v:
The Journal of Dermatology. 46:358-360
The combination therapy of dabrafenib and trametinib revolutionized the treatment for BRAF V600-mutated melanoma. Various adverse events have been reported for this treatment, most notably fever. Herein, we report two cases of novel an adverse event,
Autor:
Kazuki Omoteyama, Toshiyuki Sato, Kouhei Nagai, Mitsumi Arito, Tetsuhiko Matsuura, Kazuki Okamoto, Tomohiro Kato, Masaaki Sato, Yoshinao Soma, Manae S. Kurokawa, Naoya Suematsu
Publikováno v:
Journal of Dermatological Science. 87:36-49
Psoriasis is a refractory inflammatory disease, however, its pathophysiology is still not fully understood.We tried to identify novel serum peptides associated with the pathophysiology of psoriasis.Serum peptides from 24 patients with psoriasis vulga
Autor:
Mayuko Mutho, Masaya Ikuno, Yoshinao Soma, Kana Oishi, Tatsuro Okano, Tamihiro Kawakami, Chihiro Saitoh, Takafumi Kadono, Yu Kubo, Hiroyuki Ohashi, Maya Matsuoka
Publikováno v:
Skin Cancer. 30:108-112
Publikováno v:
International Journal of Dermatology. 55:1388-1390
Autor:
Tomohisa Hirobe, Sora Takeuchi, Kowichi Jimbow, Yoshinao Soma, Tamihiro Kawakami, Kayoko Osumi, Munenari Itoh, Tatsuro Okano
Publikováno v:
The Journal of investigative dermatology. 138(1)
Induced pluripotent stem (iPS) cells have the ability to differentiate into multiple cell types in the body and have an unlimited growth potential. However, iPS cell-derived melanocytes produced by existing protocols have significant limitations in d
Autor:
Sora Takeuchi, Kazuo Suzuki, Tamihiro Kawakami, Akihiro Ishizu, Yoshihiro Arimura, Fuyu Ito, Tatsuro Okano, Yoshinao Soma
Publikováno v:
Journal of dermatological science. 87(1)
Publikováno v:
International Journal of Dermatology. 54:e323-e325
Publikováno v:
Clinical and Experimental Dermatology. 38:730-736
Summary Background The long-term prognosis of Henoch–Schonlein purpura (HSP) is determined by the severity of renal involvement, known as HSP nephritis, which varies considerably from patient to patient. There is now increasing evidence that dysreg
Publikováno v:
The Journal of Dermatology. 40:511-515
Eosinophilic granulomatosis with polyangiitis (EGPA), also known as Churg-Strauss syndrome, is an antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis characterized by a history of asthma, hypereosinophilia. The prevalence of ANCA in EGPA